Answers are grounded in this paper and cite their sources.
Recent advances in clinical nutrition underscore the promising role of immunonutrition and tailored nutrient supplementation in improving clinical outcomes among malnourished and critically ill patients. However, despite accumulating data, mechanistic understanding and consistent clinical translation remain limited. Emerging evidence suggests that specific nutrient pathways, such as branched-chain amino acid metabolism and immunomodulatory formulae, are associated with differential patient outcomes but are not yet routinely integrated with clinical protocols or standardised metrics [1].
No takes yet. Share an insight, caveat, or question.
Doloksaribu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: